Cite
HARVARD Citation
Lewis, A. et al. (2017). Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler®. Respiratory medicine. pp. 179-188. [Online].